| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/03/2004 | US6686339 Nucleic acid molecules encoding inclusion membrane protein C of Chlamydia |
| 02/03/2004 | US6686333 Inhibition of HIV replication using soluble Tat peptide analogs |
| 02/03/2004 | US6686332 Method of treating depressed reticuloendothelial system function |
| 02/03/2004 | US6686200 Methods and compositions for the large scale production of recombinant adeno-associated virus |
| 02/03/2004 | US6686198 Preventing or antagonizing signaling pathway in cell for growth factor of tgf-beta family resulting in neuronal differentiation |
| 02/03/2004 | US6686190 Methods for enhancing the production of viral vaccines in cell culture |
| 02/03/2004 | US6686188 Polynucleotide encoding a human myosin-like polypeptide expressed predominantly in heart and muscle |
| 02/03/2004 | US6686180 Generating microorganismal gene expression inhibitors; obtain microorganism, culture, express modulators of gene activity in culture, recover gene expression inhibitors |
| 02/03/2004 | US6686179 Polypeptide for use in the treatment of thrombosis, cancer, inflammation, autoimmune, and bone disorders |
| 02/03/2004 | US6686178 Fusion proteins; interleukins; colony stimulating factors; cellular proliferation/differentiation; culturing bone marrow or peripheral blood cells; natural killer cells |
| 02/03/2004 | US6686177 Delayed onset of action |
| 02/03/2004 | US6686175 IP-10/MIG receptor designated CXCR3, nucleic acids, and methods of use therefor |
| 02/03/2004 | US6686163 Coding sequence haplotype of the human BRCA1 gene |
| 02/03/2004 | US6686153 PRV-1 gene and the use thereof |
| 02/03/2004 | US6686149 Methods for obtaining nucleotide sequences coding for polypeptides specifically active for larvae of S. littoralis |
| 02/03/2004 | US6686144 Adsorption of polyampholytes to charged surfaces and assays incorporating same |
| 02/03/2004 | US6685947 Derived from canine distemper virus |
| 02/03/2004 | US6685946 Cold-adapted equine influenza viruses |
| 02/03/2004 | US6685945 Cloned Leptospira outer membrane protein |
| 02/03/2004 | US6685944 Modification of immunogenic epitopes of the hepatitis c virus core protein to elicit an enhanced immune response |
| 02/03/2004 | US6685943 Fibronectin binding protein compositions and methods of use |
| 02/03/2004 | US6685941 Immuosuppressant |
| 02/03/2004 | US6685934 Neurodegenerative diseases. |
| 02/03/2004 | US6685933 Interferon α hybrids |
| 02/03/2004 | US6685932 Coiled-coil dimer derived antagonists of 4-helix bundle cytokines, design and uses thereof |
| 02/03/2004 | CA2234151C Urogenital carcinoma tlp complex peptides and antibodies thereof |
| 02/03/2004 | CA2118594C Max: a helix-loop-helix zipper protein that forms a sequence-specific dna-binding complex with myc and mad |
| 02/03/2004 | CA2091636C Method for suppressing coloring of human serum albumin |
| 02/03/2004 | CA2025597C Vaccine against lyme disease |
| 02/03/2004 | CA1341450C Methods and compositions for the preparation of treponema pallidum antigens, including purified antigens and dna sequences coding therefor |
| 02/02/2004 | WO2003099035A1 Process for the isolation and purification of a glycoprotein avidin |
| 02/02/2004 | CA2431773A1 Process for the isolation of purification of a glycoprotein avidin |
| 01/31/2004 | CA2432676A1 Development of an in vivo functional assay for proteases |
| 01/31/2004 | CA2396350A1 Methods of identifying selective .beta.-1-adrenergic receptor antagonists |
| 01/29/2004 | WO2004010146A1 Screening method and anti-tumor drug candidate obtained therefrom |
| 01/29/2004 | WO2004010101A2 Detection of chemical ligation using fluorescence quenching leaving groups |
| 01/29/2004 | WO2004009850A1 Hcv replication system and methods of use thereof |
| 01/29/2004 | WO2004009845A2 Methods of screening for schizophrenia |
| 01/29/2004 | WO2004009841A2 Method of identifying genes involved in cell growth regulation |
| 01/29/2004 | WO2004009836A2 Pr/set-domain containing nucleic acids, polypeptides, antibodies and methods of use |
| 01/29/2004 | WO2004009822A2 Use of specific myb genes for the production of transgenic plants tolerant to biotic and abiotic stresses |
| 01/29/2004 | WO2004009819A2 Polypeptides with a signal sequence comprising an fivsi motif and olynucleotides encoding therefor |
| 01/29/2004 | WO2004009817A1 Nucleic acid encoding mirafiori lettuce virus protein and utilization thereof |
| 01/29/2004 | WO2004009812A1 Novel protein participating in nuclear migaration of substance in nerve cells, gene encoding the protein and utilization of the same |
| 01/29/2004 | WO2004009811A1 A gene entrain system with the core sequence of histone |
| 01/29/2004 | WO2004009810A2 Transgenic animal models of hrv with humani icam-1 sequences |
| 01/29/2004 | WO2004009802A2 gM-NEGATIVE EHV-MUTANTS WITHOUT HETEROLOGOUS ELEMENTS |
| 01/29/2004 | WO2004009799A2 Ion channel receptor and uses thereof |
| 01/29/2004 | WO2004009797A2 Protein modification and maintenance molecules |
| 01/29/2004 | WO2004009791A2 Modulators of b-lymphocyte activation, myosin-1f compositions and methods of use |
| 01/29/2004 | WO2004009788A2 Fluorescent proteins, nucleic acids encoding them and methods for making and using them |
| 01/29/2004 | WO2004009786A2 Modulators of leukocyte activation, bic compositions and methods of use |
| 01/29/2004 | WO2004009785A2 IgG Fc/HIV-gp120/C3d FUSION PROTEIN |
| 01/29/2004 | WO2004009783A2 Truncated rgr in t cell malignancy |
| 01/29/2004 | WO2004009781A2 Process for regulating gene expression |
| 01/29/2004 | WO2004009780A2 Preventing ischemia-induced cell damage |
| 01/29/2004 | WO2004009775A2 Methods and compositions relating to chimeric nicotinic receptor subunits |
| 01/29/2004 | WO2004009774A2 Protein conjugates with a water-soluble biocompatible, biogradable polymer |
| 01/29/2004 | WO2004009772A2 Npc1l1 (npc3) and methods of use thereof |
| 01/29/2004 | WO2004009770A2 Methods and compositions for modulating agonist-induced downregulation of g protein-coupled receptors |
| 01/29/2004 | WO2004009764A2 Methods and compositions concerning altered yellow fever virus strains |
| 01/29/2004 | WO2004009763A2 Use of vaccinia virus deleted for the e3l gene as a vaccine vector |
| 01/29/2004 | WO2004009762A2 Flea and tick octopamine receptor nucleic acid molecules, proteins and thereof |
| 01/29/2004 | WO2004009759A2 Novel proteins in enteroaggregative escherichia coli (eaec) useful for diagnosis and therapy of eaec infections |
| 01/29/2004 | WO2004009637A1 Anti-angiogenic peptides |
| 01/29/2004 | WO2004009636A2 Gnrh modulator |
| 01/29/2004 | WO2004009635A2 Novel polypeptides and nucleic acids encoding same |
| 01/29/2004 | WO2004009634A2 Novel polypeptides and nucleic acids encoding same |
| 01/29/2004 | WO2004009633A1 Serotonin receptor |
| 01/29/2004 | WO2004009632A2 Method for the production of an immunostimulating mucin (muc1) |
| 01/29/2004 | WO2004009631A2 Human gnrh (type 2) receptor |
| 01/29/2004 | WO2004009630A1 Regulation of human serotonin receptor |
| 01/29/2004 | WO2004009629A1 Monomeric insulin |
| 01/29/2004 | WO2004009628A1 Inhibition of cell division based use of analogs of neuropeptide y |
| 01/29/2004 | WO2004009627A1 Pegylated erythropoietic compounds |
| 01/29/2004 | WO2004009626A1 Novel gene associated with rheumatoid arthritis |
| 01/29/2004 | WO2004009625A2 PEPTIDES AND PEPTIDE DERIVATIVES FOR THE TREATMENT OF α-SYNUCLEIN-RELATED DISEASES |
| 01/29/2004 | WO2004009624A2 Three finger toxin fold protein |
| 01/29/2004 | WO2004009622A2 Protein complexes of cellular networks underlying the development of cancer and other diseases |
| 01/29/2004 | WO2004009621A2 Polypeptides of nontypeable haemophilus influenzae |
| 01/29/2004 | WO2004009620A1 Novel na+/h+ exchanger inhibitor peptide (pinhe) and applications thereof |
| 01/29/2004 | WO2004009619A2 Protein complexes of the tip60 transcriptional activator protein |
| 01/29/2004 | WO2004009618A2 Recombinant production of mixtures of antibodies |
| 01/29/2004 | WO2004009617A1 NOVEL Notch-ORIGIN POLYPEPTIDES AND BIOMARKERS AND REAGENTS USING THE SAME |
| 01/29/2004 | WO2004009616A2 Ghrelin analogs |
| 01/29/2004 | WO2004009615A2 Cd40-ligand lacking native-pattern glycosylation |
| 01/29/2004 | WO2004009614A2 Receptor (sstr4)- selective somatostatin analogs |
| 01/29/2004 | WO2004009133A1 Adenoviral vector incorporating zipper peptide-modified fiber protein and uses thereof |
| 01/29/2004 | WO2004009131A1 Tumor treating combinations, compositions and methods |
| 01/29/2004 | WO2004009130A1 Tumor treating composition and methods |
| 01/29/2004 | WO2004009128A1 Anti-angiogenic peptides |
| 01/29/2004 | WO2004009126A1 Targeted agents for nerve regeneration |
| 01/29/2004 | WO2004009124A2 Ghrelin-carrier conjugates |
| 01/29/2004 | WO2004009116A2 Hapten-carrier conjugates comprising virus like particles and uses thereof |
| 01/29/2004 | WO2004009115A1 Rotavirus vp6 subunit |
| 01/29/2004 | WO2004009110A1 Peptide m as apoptosis inducing agent |
| 01/29/2004 | WO2004009032A2 Method and composition for treating and preventing hepatitis b infection and symptoms thereof |
| 01/29/2004 | WO2004009027A2 Method and composition for treating and preventing herpesvirus infection |
| 01/29/2004 | WO2004009022A2 Method for augmenting vision in persons suffering from photoreceptor cell degeneration |
| 01/29/2004 | WO2004009021A2 Rapid, efficient purification of hsv-specific t-lymphocytes and hsv antigens identified via same |